Polypharmacy and potentially inappropriate medication use in hospitalized geriatric patients: a prospective evaluation using the American geriatrics society 2023 Beers criteria

Sarfaraz M.; Rizwan R. Biradar; Khuteja Parveen

doi:10.18203/2394-6040.ijcmph20264101

Authors

Sarfaraz M. Department of Pharmaceutics, NET Pharmacy College, Raichur, Karnataka, India https://orcid.org/0000-0003-1953-4355
Rizwan R. Biradar Department of Pharmacy Practice, NET Pharmacy College, Raichur, Karnataka, India
Khuteja Parveen Department of Pharmacy Practice, NET Pharmacy College, Raichur, Karnataka, India

DOI:

https://doi.org/10.18203/2394-6040.ijcmph20264101

Keywords:

Tertiary care hospital, Prescription appropriateness, Potentially inappropriate medications, Beers criteria, Geriatric pharmacotherapy, Polypharmacy

Abstract

Background: Elderly inpatients are disproportionately burdened by polypharmacy and potentially inappropriate medication (PIM) use, driven by age-related pharmacokinetic change, multimorbidity, and fragmented prescribing. Systematic Beers criteria-based prescription review is rarely practised in Indian tertiary care settings, and regional economic data on this problem are lacking.

Methods: A prospective observational study was conducted from January-June 2025 at a 1200-bed tertiary care teaching hospital in Raichur, Karnataka, enrolling 100 in-patients aged ≥65 years from general medicine, orthopaedics, ophthalmology, and surgery departments. Prescribed drugs were evaluated against the four categories of the American Geriatrics Society (AGS) 2023 Beers Criteria, and drug costs were used to compute the economic burden of inappropriate prescribing. Descriptive statistics, chi-square, Pearson correlation, and one-way ANOVA were applied.

Results: Female patients constituted 61% of the cohort; 57% were aged 65-70 years. Mean drugs per prescription was 11.13±3.72 (range: 5-22). A total of 293 PIM occurrences were identified in 99 of 100 patients (99%); mean 2.93±1.67 per patient. Proton pump inhibitors (40.3%), non-steroidal anti-inflammatory drugs (14.7%), and tramadol (12.6%) were the most prevalent inappropriate classes. Mean PIM-attributable cost was INR 1021.98±1113.04 per patient (13.64% of total inpatient drug expenditure); one-way ANOVA across three cost strata showed significant differences (F=18.87; p<0.001).

Conclusions: PIM use was observed in a substantial proportion of elderly inpatients, with proton pump inhibitors, NSAIDs, and opioids frequently identified. The findings support continued individualized medication review, Beers Criteria integration, and physician–pharmacist collaboration to optimize safe, effective, and patient-centered geriatric pharmacotherapy.

References

United Nations, Department of Economic and Social Affairs, Population Division. World Population Prospects 2022: Summary of Results. New York: United Nations. 2022.

World Health Organization. Ageing and health. Geneva: WHO; 2021. Available at: https://www.who.int/news-room/fact-sheets/detail/ageing-and-health. Accessed on 28 May 2026.

Khan MR, Malik MA, Akhtar SN, Yadav S, Patel R. Multimorbidity and its associated risk factors among older adults in India. BMC Public Health. 2022;22(1):746.

Tinetti ME, Fried TR, Boyd CM. Designing health care for the most common chronic condition-multimorbidity. JAMA. 2012;307(23):2493-4.

Masnoon N, Shakib S, Kalisch-Ellett L, Caughey GE. What is polypharmacy? A systematic review of definitions. BMC Geriatr. 2017;17(1):230.

Krishnananda KK, Chethan TK, Sreelakshmi RK. Polypharmacy and prescription appropriateness in geriatric patients: a prospective observational study. Asian J Pharm Clin Res. 2023;16(5):54-8.

Wazir WM, Nayeem A, Khayum N. Assessment of potentially inappropriate medications and prescribing practices in geriatrics using the 2015 AGS Beers Criteria. Int J Pharm Sci Res. 2020;11(7):3385-91.

Mangoni AA, Jackson SH. Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Br J Clin Pharmacol. 2004;57(1):6-14.

Alhawassi TM, Krass I, Bajorek BV, Pont LG. A systematic review of the prevalence and risk factors for adverse drug reactions in the elderly in the acute care setting. Clin Interv Aging. 2014;9:2079-86.

Fick DM, Semla TP, Beizer J, Brandt N, Dombrowski R, DuBeau CE, et al. American Geriatrics Society 2015 updated Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2015;63(11):2227-46.

American Geriatrics Society 2023 updated AGS Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2023;71(7):2052-81.

Harugeri A, Joseph J, Parthasarathi G, Ramesh M, Guido S. Potentially inappropriate medication use in elderly patients: a study of prevalence and predictors in two teaching hospitals. J Postgrad Med. 2010;56(3):186-91.

Rakesh KB, Bhaskaran S, Krishnakumar C. Polypharmacy and prescribing appropriateness in geriatric outpatients. J Pharm Pract Community Med. 2016;2(4):130-4.

Nashiya F, John E, George A, Theres MC. Prevalence of potentially inappropriate prescribing in geriatric inpatients: a prospective observational study. Int J Pharm Sci Rev Res. 2023;79(1):14-9.

Bertakis KD, Azari R, Helms LJ, Callahan EJ, Robbins JA. Gender differences in the utilization of health care services. J Fam Pract. 2000;49(2):147-52.

Vetrano DL, Palmer K, Marengoni A, Marzetti E, Lattanzio F, Roller-Wirnsberger R, et al. Frailty and multimorbidity: a systematic review and meta-analysis. J Gerontol A Biol Sci Med Sci. 2019;74(5):659-66.

Rechel B, Grundy E, Robine JM, Cylus J, Mackenbach JP, Knai C, et al. Ageing in the European Union. Lancet. 2013;381(9874):1312-22.

Cullinan S, O'Mahony D, Byrne S. Application of the STOPP/START criteria: a systematic review of the prevalence of potentially inappropriate prescribing in older adults. Drugs Aging. 2014;31(8):549-63.

Viktil KK, Blix HS, Moger TA, Reikvam A. Polypharmacy as commonly defined is an indicator of limited value in the assessment of drug-related problems. Br J Clin Pharmacol. 2007;63(2):187-95.

Tinetti ME, Bogardus ST, Agostini JV. Potential pitfalls of disease-specific guidelines for patients with multiple conditions. N Engl J Med. 2004;351(27):2870-4.

Page AT, Clifford RM, Potter K, Schwartz D, Etherton-Beer CD. The feasibility and effect of deprescribing in older adults on mortality and health: a systematic review and meta-analysis. Br J Clin Pharmacol. 2016;82(3):583-623.

Regina MAF de Oliveira, Brites D, Falcao L, Melo MN. Prevalence of potentially inappropriate medication use in geriatric inpatients using the 2019 AGS Beers Criteria. Pharmacy (Basel). 2022;10(4):97.

Motallebzadeh N, Jayaprakash G, Mohammadi E. Evaluation of rationality of geriatric patients' prescription based on Beers criteria in a tertiary care hospital in India. Open Access Maced J Med Sci. 2019;7(6):987-91.

Ruqiya S, Rao KY, Devarajan S, Vedha P. Prescribing patterns in elderly patients using Beers criteria. Asian J Pharm Clin Res. 2019;12(7):116-9.

Rishabh S, Gupta A, Dahiya M, Gupta M. Prospective study to evaluate compliance with updated Beers criteria (2019) in elderly patients. Int J Basic Clin Pharmacol. 2020;9(5):734-40.

McDonald E, Wu PE, Rashidi B, McCarthy L, Forster AJ, Kyeremanteng K, et al. The MedSafer Study: electronic decision support for deprescribing in hospitalized older adults. J Am Geriatr Soc. 2019;67(6):1137-44.

Zint K, Haefeli WE, Glynn RJ, Mogun H, Avorn J, Sturmer T. Impact of drug interactions, dosage, and duration of therapy on the risk of hip fracture associated with benzodiazepine use in older adults. Pharmacoepidemiol Drug Saf. 2010;19(12):1248-55.

Billioti de Gage S, Moride Y, Ducruet T, Kurth T, Verdoux H, Tournier M, et al. Benzodiazepine use and risk of Alzheimer's disease: case-control study. BMJ. 2014;349:g5205.

Rao AS, Camilleri M. Review article: metoclopramide and tardive dyskinesia. Aliment Pharmacol Ther. 2010;31(1):11-9.

Lau DT, Kasper JD, Potter DE, Lyles A, Bennett RG. Hospitalization and death associated with potentially inappropriate medication prescriptions among elderly nursing facility residents. Arch Intern Med. 2005;165(1):68-74.

Clark CM, Burkett K, Schweitzer M. Review of NP literature regarding advanced practice nursing interventions with elderly patients taking potentially inappropriate medications. J Am Acad Nurse Pract. 2012;24(3):113-22.

Seema A, Mohan P, Rao GR. Assessment of potentially inappropriate medications in geriatric patients using Beers criteria and evaluation using Morisky medication adherence scale. Int J Pharm Pharm Sci. 2017;9(4):151-4.